-
Signature
-
/s/ Sarah Dale, Attorney-in-Fact for Srinivas Tallapragada
-
Issuer symbol
-
CRM
-
Transactions as of
-
27 Nov 2023
-
Net transactions value
-
-$694,003
-
Form type
-
4
-
Filing time
-
28 Nov 2023, 16:58:30 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
CRM |
Common Stock |
Options Exercise |
$390,830 |
+2,420 |
+4.1% |
$161.50 |
61,350 |
27 Nov 2023 |
Direct |
F1 |
| transaction |
CRM |
Common Stock |
Options Exercise |
$1,168,381 |
+7,580 |
+12% |
$154.14 |
68,930 |
27 Nov 2023 |
Direct |
F1 |
| transaction |
CRM |
Common Stock |
Sale |
$1,071,896 |
-4,763 |
-6.9% |
$225.05 |
64,167 |
27 Nov 2023 |
Direct |
F1, F2 |
| transaction |
CRM |
Common Stock |
Sale |
$1,181,317 |
-5,237 |
-8.2% |
$225.57 |
58,930 |
27 Nov 2023 |
Direct |
F1, F3 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-2,420 |
-100% |
$0.000000* |
0 |
27 Nov 2023 |
Common Stock |
2,420 |
$161.50 |
Direct |
F1, F4 |
| transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-7,580 |
-5.5% |
$0.000000 |
131,145 |
27 Nov 2023 |
Common Stock |
7,580 |
$154.14 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: